Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

EM TopicsDeep vein thrombosis

EM · Deep vein thrombosis

Deep vein thrombosis (emergency department diagnosis and management)

Also known as DVT · Venous thrombosis · Deep venous thrombosis

Deep vein thrombosis — the Wells-DVT risk score (the clinical signs, the risk factors, the alternative diagnosis — reproduced), the D-dimer and the compression ultrasound strategy, the anticoagulation management (the apixaban or the rivaroxaban first-line, the enoxaparin, the warfarin), the compression stockings, the PE cross-link, and the Wells-DVT-versus-clinical-probability approach. ACEM-primary, globally tagged.

medium26 referencesUpdated 26 July 202617 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

ACEMFRCEMABEMFRCPCCCFPEMEBEEM

Red flags

  • A DVT and a PE are one disease — the venous thromboembolism — and the management of the DVT prevents the PE
  • An iliofemoral DVT (the entire leg swollen, the phlegmasia) is a high-risk presentation that may need the thrombolysis, not just the anticoagulation
  • A DVT in a patient with an active cancer is managed with a DOAC (apixaban or rivaroxaban) or the LMWH — not warfarin alone; the LMWH is preferred in luminal gastrointestinal or genitourinary cancers — the cancer-associated thrombosis has its own pathway
  • The anticoagulation is started as soon as the diagnosis is confirmed (or the probability is high) — do not wait for the ultrasound if the Wells is high and the D-dimer is positive
  • The recurrent DVT or the DVT at an unusual site (the arm, the mesenteric) prompts the thrombophilia and the malignancy screen
On this page

Related topics

  • Pulmonary embolism (acute, in the emergency department)
  • Acute limb ischaemia (the emergency of the 6 Ps)
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

ACEMFRCEMABEMFRCPCCCFPEMEBEEM

Red flags

  • A DVT and a PE are one disease — the venous thromboembolism — and the management of the DVT prevents the PE
  • An iliofemoral DVT (the entire leg swollen, the phlegmasia) is a high-risk presentation that may need the thrombolysis, not just the anticoagulation
  • A DVT in a patient with an active cancer is managed with a DOAC (apixaban or rivaroxaban) or the LMWH — not warfarin alone; the LMWH is preferred in luminal gastrointestinal or genitourinary cancers — the cancer-associated thrombosis has its own pathway
  • The anticoagulation is started as soon as the diagnosis is confirmed (or the probability is high) — do not wait for the ultrasound if the Wells is high and the D-dimer is positive
  • The recurrent DVT or the DVT at an unusual site (the arm, the mesenteric) prompts the thrombophilia and the malignancy screen
The one-line answer

Deep vein thrombosis is the proximal half of a single disease — the venous thromboembolism — and you manage the DVT to prevent the PE. Apply the Wells-DVT score: unlikely (0 to 1) sends a high-sensitivity D-dimer (a negative rules out), likely (2 or more) goes straight to compression ultrasound and start a DOAC if the scan is delayed. First-line anticoagulation is a DOAC (apixaban or rivaroxaban); LMWH for cancer and pregnancy; 3 months for a provoked DVT, longer (often indefinite) for unprovoked or cancer-associated.[16][26]

Meet the patient

A 68-year-old man presents three weeks after an uncomplicated total knee replacement with a swollen, tender left calf — 4 cm larger than the right at 10 cm below the tibial tuberosity, with pitting oedema confined to the symptomatic leg. He is afebrile, pulse 92, SpO2 97 per cent on room air, and the registrar asks whether to send a D-dimer "to rule the clot out".[3]

The question that decides his next hour is the question that decides every DVT: is this DVT likely or unlikely? The Wells-DVT score answers it at the bedside, and the answer routes him either to the D-dimer (if unlikely) or straight to the compression ultrasound (if likely). Reach for the score first, not the blood form.[1]

Emergency Medicine Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Emergency Medicine fellowship library.

Sign in to continueSee pricing
References26ShowHide
  1. [1]Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, 2012.PMID 22315268
  2. [17]Garcia DA, Baglin TP, Weitz JI, et al. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, 2012.PMID 22315264
  3. [18]Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest, 1998.PMID 9822057
  4. [2]Stals MAM, Moumneh T, Ainle FN, et al. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data J Thromb Haemost, 2023.PMID 36696189
  5. [3]Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management Lancet, 1997.PMID 9428249
  6. [4]Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N Engl J Med, 1999.PMID 10089183
  7. [5]Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group N Engl J Med, 1998.PMID 9459643
  8. [6]Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med, 2010.PMID 21128814
  9. [7]Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism N Engl J Med, 2013.PMID 23808982
  10. [8]Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med, 2009.PMID 19966341
  11. [9]Büller HR, Décousus H, Grosso MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism N Engl J Med, 2013.PMID 23991658
  12. [10]Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med, 2003.PMID 12853587
  13. [11]Lee AYY, Kamphuisen PW, Meyer G, et al. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial JAMA, 2015.PMID 26284719
  14. [12]Decousus H, Prandoni P, Mismetti P, et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs N Engl J Med, 2010.PMID 20860504
  15. [13]Khorana AA, Soff GA, Kakkar AK, et al. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer N Engl J Med, 2019.PMID 30786186
  16. [14]Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation N Engl J Med, 2015.PMID 26095867
  17. [15]Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial Lancet, 2014.PMID 24315521
  18. [16]Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report Chest, 2016.PMID 26867832
  19. [19]Agnelli G, Becattini C, Meyer G, et al. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer N Engl J Med, 2020.PMID 32223112
  20. [20]Young AM, Marshall A, Thirlwall J, et al. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) J Clin Oncol, 2018.PMID 29746227
  21. [21]Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome Blood, 2018.PMID 30002145
  22. [22]Pollack CV Jr, Reilly PA, van Ryn J, et al. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis N Engl J Med, 2017.PMID 28693366
  23. [23]Connolly SJ, Crowther M, Eikelboom JW, et al. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors N Engl J Med, 2019.PMID 30730782
  24. [24]Partsch H, Blättler W Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin J Vasc Surg, 2000.PMID 11054217
  25. [25]Le Gal G, Robert-Ebadi H, Thiruganasambandamoorthy V, et al. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis. JAMA, 2026.PMID 41490105
  26. [26]Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012.PMID 22315276

Test yourself

Practise what you just read

  • 8 MCQs
Emergency Medicine Pro

$29/ monthor $279 / year

The complete Emergency Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousDamage control resuscitation in traumaDamage control resuscitationNextDisaster and mass casualtyDisaster & mass casualty

Related topics

  • Pulmonary embolism (acute, in the emergency department)
  • Acute limb ischaemia (the emergency of the 6 Ps)